{"protocolSection":{"identificationModule":{"nctId":"NCT05495269","orgStudyIdInfo":{"id":"QC-205"},"organization":{"fullName":"Qlaris Bio, Inc.","class":"INDUSTRY"},"briefTitle":"Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)","officialTitle":"Pilot, Open-label Study of Safety and Tolerability of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)"},"statusModule":{"statusVerifiedDate":"2023-03","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-11-23","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-01-25","type":"ACTUAL"},"completionDateStruct":{"date":"2023-03-20","type":"ACTUAL"},"studyFirstSubmitDate":"2022-08-02","studyFirstSubmitQcDate":"2022-08-08","studyFirstPostDateStruct":{"date":"2022-08-10","type":"ACTUAL"},"dispFirstSubmitDate":"2023-03-21","dispFirstSubmitQcDate":"2023-03-22","dispFirstPostDateStruct":{"date":"2023-03-27","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-03-22","lastUpdatePostDateStruct":{"date":"2023-03-27","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Qlaris Bio, Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Open-label study of an investigational product (IP), QLS-101, with 28-day every morning (QAM) dosing to both eyes (OU) in adolescents with SWS who have clinical evidence of glaucoma and/or ocular hypertension (OHT) related to SWS elevated EVP in at least one eye."},"conditionsModule":{"conditions":["Sturge-Weber Syndrome","Glaucoma","Ocular Hypertension"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","interventionModelDescription":"Open-label, single treatment","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":2,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"QLS-101, 2.0%","type":"EXPERIMENTAL","description":"Qlaris' investigational product, QLS-101, 2.0% concentration, ocular administration (eye drop), given once daily in the morning to both eyes","interventionNames":["Drug: QLS-101 ophthalmic solution, 2.0 %"]}],"interventions":[{"type":"DRUG","name":"QLS-101 ophthalmic solution, 2.0 %","description":"ophthalmic solution in a single use dropper vial","armGroupLabels":["QLS-101, 2.0%"],"otherNames":["QLS-101"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Ocular safety","description":"Incidence of ocular treatment emergent adverse events (TEAEs)","timeFrame":"Over 28 days"},{"measure":"Systemic safety","description":"Incidence of systemic TEAEs","timeFrame":"Over 28 days"}],"secondaryOutcomes":[{"measure":"Ocular hypotensive effectiveness","description":"Mean change in intraocular pressure (IOP) (mmHg and % change) from baseline following 28 days dosing with QLS-101","timeFrame":"28 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Between 12 and 19 years of age at Screening.\n* Diagnosed with SWS\n* Elevated IOP\n* Willing to continue current dosing regimen of IOP-lowering medications\n* Able to provide informed consent and follow study instructions\n\nExclusion Criteria:\n\n* Expected to undergo IOP-lowering surgery\n* Incisional or laser surgery of any type 4 months prior to study\n* Ocular infection, inflammation, clinically significant blepharitis or conjunctivitis, history of herpes simplex keratitis in either eye\n* History of or active clinically significant ocular disease\n* Use of topical ocular corticosteroids in the 6 weeks prior to study\n* Patient cannot be applanated or tolerate IOP measurements\n* Patient is pregnant or lactating\n* Uncontrolled systemic disease that can interfere with study participation\n* Inability to self-dose or identify a caregiver for all study eye drop administration","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","maximumAge":"19 Years","stdAges":["CHILD","ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Sharon Freedman, M.D.","affiliation":"Duke Eye Center","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Duke Eye Center","city":"Durham","state":"North Carolina","zip":"27710","country":"United States","geoPoint":{"lat":35.99403,"lon":-78.89862}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000013341","term":"Sturge-Weber Syndrome"},{"id":"D000020526","term":"Brain Stem Infarctions"},{"id":"D000005901","term":"Glaucoma"},{"id":"D000009798","term":"Ocular Hypertension"},{"id":"D000007715","term":"Klippel-Trenaunay-Weber Syndrome"},{"id":"D000013577","term":"Syndrome"}],"ancestors":[{"id":"D000004194","term":"Disease"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000005128","term":"Eye Diseases"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000020521","term":"Stroke"},{"id":"D000007238","term":"Infarction"},{"id":"D000007511","term":"Ischemia"},{"id":"D000009336","term":"Necrosis"},{"id":"D000000798","term":"Angiomatosis"},{"id":"D000006391","term":"Hemangioma"},{"id":"D000009383","term":"Neoplasms, Vascular Tissue"},{"id":"D000009370","term":"Neoplasms by Histologic Type"},{"id":"D000009369","term":"Neoplasms"},{"id":"D000020752","term":"Neurocutaneous Syndromes"}],"browseLeaves":[{"id":"M9714","name":"Hypertension","relevance":"LOW"},{"id":"M16045","name":"Syndrome","asFound":"Syndrome","relevance":"HIGH"},{"id":"M8703","name":"Glaucoma","asFound":"Glaucoma","relevance":"HIGH"},{"id":"M12421","name":"Ocular Hypertension","asFound":"Ocular Hypertension","relevance":"HIGH"},{"id":"M10425","name":"Klippel-Trenaunay-Weber Syndrome","asFound":"Weber Syndrome","relevance":"HIGH"},{"id":"M15821","name":"Sturge-Weber Syndrome","asFound":"Sturge-Weber Syndrome","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M22001","name":"Brain Stem Infarctions","asFound":"Weber Syndrome","relevance":"HIGH"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M7961","name":"Eye Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M3816","name":"Angiomatosis","relevance":"LOW"},{"id":"M9169","name":"Hemangioma","relevance":"LOW"},{"id":"M12018","name":"Neoplasms, Vascular Tissue","relevance":"LOW"},{"id":"M12005","name":"Neoplasms by Histologic Type","relevance":"LOW"},{"id":"M22199","name":"Neurocutaneous Syndromes","relevance":"LOW"},{"id":"T3248","name":"Klippel-Trenaunay Syndrome","asFound":"Weber Syndrome","relevance":"HIGH"},{"id":"T4428","name":"Parkes Weber Syndrome","asFound":"Sturge-Weber Syndrome","relevance":"HIGH"},{"id":"T5905","name":"Weber Syndrome","asFound":"Weber Syndrome","relevance":"HIGH"},{"id":"T5493","name":"Sturge-Weber Syndrome","asFound":"Sturge-Weber Syndrome","relevance":"HIGH"}],"browseBranches":[{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC11","name":"Eye Diseases"},{"abbrev":"BC04","name":"Neoplasms"},{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"},{"abbrev":"BC17","name":"Skin and Connective Tissue Diseases"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000009883","term":"Ophthalmic Solutions"}],"ancestors":[{"id":"D000019999","term":"Pharmaceutical Solutions"}],"browseLeaves":[{"id":"M12504","name":"Ophthalmic Solutions","asFound":"Alfa","relevance":"HIGH"},{"id":"M21550","name":"Pharmaceutical Solutions","relevance":"LOW"}],"browseBranches":[{"abbrev":"PhSol","name":"Pharmaceutical Solutions"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}